BBC News - November 13, 2005
Although the research is still at an early stage, they hope it could eventually lead to a practical and cost effective new way to combat the virus.
As of December 2004, there are 39.4 million people living with HIV/AIDS.
The research, by the US National Cancer Institute, is published in Proceedings of the National Academy of Sciences.
Most HIV transmission occurs on the surfaces of the gut and reproductive areas which are normally coated with a layer of bacteria.
The researchers modified one of these bacteria - a form of E.coli - so that it began to secrete proteins that block HIV from infecting its target cells.
When the modified bacteria were introduced in mice, they successfully colonised parts of the lower gut, and were also found in lower concentrations in the vagina.
Better method
Writing in the journal, the researchers said there was an urgent need for new ways to prevent the spread of HIV, especially in the developing world.
Scientists have been working on microbicide creams and gels which can be applied to the genitals to block HIV infection.
However, the researchers say the fact they need to be regularly applied before sex is likely to limit their use.
They believe their approach has the potential to offer more lasting protection.
"Bacteria are simple and practical to manufacture, store, distribute and administer, and they are far less expensive than protein-based microbicides," they write.
They also believe the method could be adapted to deliver bacteria secreting different proteins to different parts of the body.
Although primarily designed to prevent new HIV infections, they believe it could also be used, in combination with drug therapy, to treat people already carrying the virus.
Work needed
Dr Tim Farley, of the World Health Organization, said: "In principle a technique such as this which enhances the body's defences against HIV sounds like a great idea.
"Clearly there are many steps to be completed in the development and clinical testing of the product, and there may be special safety concerns over unexpected side effects due to deliberately colonising the gastrointestinal tract with genetically engineered bacteria."
Lisa Power, of the Terrence Higgins Trust said: "This research is promising and is based on a clever idea, using naturally occurring bacteria to improve resistance to transmission.
"However, we are a very long way off its practical use in humans, and until then, condoms are the best defence we have against HIV and most other sexually transmitted infections."
051113
BB051106
Copyright © 2005 - BBC. Reproduction of this article (other than one copy for personal reference) must be cleared through the BBC.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation UK, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.
Always watch for outdated information. This article first appeared in 2005. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2005. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.
.